The present invention provides a process of preparing a crystalline azithromycin monohydrate. The process involves dissolving azithromycin in a solution containing ethanol, adding the dissolved azithromycin into water to precipitate the crystals, isolating and drying the precipitate to a water content of about 5% (w/w) to about 7% (w/w). The resulting azithromycin monohydrate is stable, exhibiting less than 2% degradation, and non-hydroscopic.

 
Web www.patentalert.com

< AI-2 compounds and analogs based on salmonella typhimurium LsrB structure

< C-aryl glucoside SGLT2 inhibitors and method

> Thermally stable crystalline epirubicin hydrochloride and method of making the same

> 4,7-dichlorofluorescein dyes as molecular probes

~ 00247